Clinical Trial Update: Dopaminergic Neurotransmission in Schizophrenia, Patients at Risk and Healthy Subjects [NA]

View source ↗

Summary

A completed clinical trial investigating dopaminergic neurotransmission in schizophrenia, including patients at risk and healthy subjects. The study was sponsor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Schizophrenia | NA | Status: COMPLETED